Durham, NC, United States of America

John Howard Sampson

This inventor holds 25 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents and 9 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Duke University, The United States of America, as Represented by the Secretary, Department of Health and Human Services, The University of Texas System. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Howard Sampson. Retrieved from https://idiyas.com/inventor/john-howard-sampson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 92.0


 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 98(Granted Patents)


Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oncolytic Poliovirus
Cancer Treatment
Bispecific Antibodies
Immune Response
DC Vaccines
Sequential Treatment
Concurrent Therapy
Allogeneic Vaccine
Assays
Oxidoreductases
25 patents (USPTO):Explore Patents

Title: John Howard Sampson: Innovator in Cancer Treatment

Introduction

John Howard Sampson is a distinguished inventor based in Durham, NC, with an impressive portfolio of 25 patents. His work primarily focuses on innovative approaches to eliciting immune responses and advancing cancer treatments, significantly contributing to the field of medical research.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compositions, methods and kits for eliciting an immune response." This invention relates to the development of compositions and kits designed to provoke an immune response specifically to at least one cytomegalovirus (CMV) antigen expressed by cancer cells. The goal is to improve strategies for treating and preventing cancer. Additionally, Sampson has patented "Oncolytic poliovirus for human tumors," which describes a chimeric poliovirus construct demonstrating remarkable anti-tumor effects in human clinical applications. This invention operates through mechanisms involving viral oncolysis and immune recruitment, ultimately leading to necrosis of the tumor without adverse effects.

Career Highlights

Sampson's career has been marked by significant associations with reputable organizations, including Duke University, where he carried out extensive research and development in the medical field. He has also held the position of Secretary at the Department of Health and Human Services (DHHS), contributing his expertise to public health initiatives.

Collaborations

Throughout his illustrious career, John Howard Sampson has collaborated with esteemed colleagues, such as Duane A. Mitchell and Darell D. Bigner. These partnerships have enriched his research endeavors and furthered innovation in cancer treatment.

Conclusion

John Howard Sampson's contributions to cancer immunotherapy through his inventions and patents have the potential to revolutionize treatment methodologies. His dedication to advancing medical science is evident through his collaborative efforts and innovative spirit, positioning him as a pivotal figure in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…